| Not Yet Recruiting | Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets NCT07511010 | Chipscreen Biosciences, Ltd. | Phase 1 |
| Not Yet Recruiting | Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets NCT07519265 | Chipscreen Biosciences, Ltd. | N/A |
| Not Yet Recruiting | Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets NCT07412015 | Chipscreen Biosciences, Ltd. | N/A |
| Not Yet Recruiting | Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease NCT07390422 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients NCT07441187 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabet NCT07321678 | Ascletis Pharma (China) Co., Limited | Phase 2 |
| Not Yet Recruiting | A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes M NCT07303803 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Not Yet Recruiting | Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidne NCT07116928 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 4 |
| Recruiting | Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine NCT07148713 | University of North Carolina, Chapel Hill | N/A |
| Recruiting | GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM NCT07314684 | Federico II University | Phase 4 |
| Recruiting | Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D NCT07005362 | University of Colorado, Denver | — |
| Completed | Detecting Type 2 Diabetes From Voice NCT07421921 | Thymia Limited | — |
| Not Yet Recruiting | Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D. NCT06912737 | Ohio State University | N/A |
| Recruiting | Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control NCT07244003 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 4 |
| Withdrawn | Embecta AID System in Adults With Type 2 Diabetes NCT06692153 | Embecta Corp. | N/A |
| Active Not Recruiting | Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers NCT07172997 | Royal College of Surgeons in Ireland - Medical University of Bahrain | — |
| Completed | Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs NCT07188935 | Al-Mustansiriyah University | N/A |
| Completed | Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequa NCT06415773 | HighTide Biopharma Pty Ltd | Phase 3 |
| Active Not Recruiting | Virtual Diabetes Group Visits Across Health Systems NCT06094491 | University of Chicago | Phase 2 |
| Recruiting | To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM NCT06293417 | Korea University Anam Hospital | N/A |
| Active Not Recruiting | A Study of RAY1225 in Participants With Type 2 Diabetes NCT06254274 | Guangdong Raynovent Biotech Co., Ltd | Phase 2 |
| Active Not Recruiting | Impact Evaluation of the Therapeutic Initiative's Type 2 Diabetes in Older Adults Portrait and Therapeutics Le NCT06733805 | University of British Columbia | N/A |
| Unknown | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus NCT06141980 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes NCT06350890 | HighTide Biopharma Pty Ltd | Phase 3 |
| Active Not Recruiting | Utilization Study and Evaluation of Educational Intervention on HbA1c Testing NCT06976541 | University of British Columbia | N/A |
| Completed | A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mell NCT05260021 | Eli Lilly and Company | Phase 3 |
| Completed | To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects. NCT06055582 | Diabetes Foundation, India | N/A |
| Unknown | Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects NCT05369078 | Newsoara Biopharma Co., Ltd. | Phase 1 |
| Completed | Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM NCT04688359 | University of Akureyri | N/A |
| Recruiting | Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) NCT05469659 | Shinshu University | Phase 2 |
| Completed | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. NCT05376930 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Unknown | Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM NCT04682795 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Completed | A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects NCT05943886 | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | Phase 1 |
| Completed | Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately NCT05376969 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Terminated | A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus NCT04754334 | Oramed, Ltd. | Phase 3 |
| Completed | Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion NCT05279911 | Sinai University | N/A |
| Unknown | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 NCT04706286 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus NCT04654390 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. NCT04634500 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. NCT04632862 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2 NCT04970940 | AJU Pharm Co., Ltd. | Phase 1 |
| Unknown | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus NCT04014023 | Daewoong Pharmaceutical Co. LTD. | Phase 2 |
| Recruiting | Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2 NCT03987308 | Beijing Hospital | N/A |
| Unknown | Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes M NCT04272359 | University of Milan | — |
| Unknown | Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction NCT03658031 | Hamad Medical Corporation | Phase 3 |
| Unknown | RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD NCT03789695 | Irina Ermolaeva | Phase 4 |
| Completed | A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Melli NCT03467932 | Oramed, Ltd. | Phase 2 |
| Completed | Single Escalating Dose Study Of HSK7653 In Healthy Subjects NCT05983289 | Haisco Pharmaceutical Group Co., Ltd. | Phase 1 |
| Completed | Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus NCT03437109 | Besins Healthcare | — |
| Withdrawn | Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM NCT03291249 | Tiziana Life Sciences LTD | Phase 2 |
| Terminated | Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients NCT03067480 | East Tennessee State University | N/A |
| Completed | SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study) NCT03050229 | Jichi Medical University | Phase 4 |
| Completed | Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Ty NCT03233178 | LMC Diabetes & Endocrinology Ltd. | — |
| Unknown | Effect of Viscous Soluble Fibres on Body Weight NCT03257449 | Unity Health Toronto | — |
| Completed | PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropat NCT03155087 | People's Hospital of Zhengzhou University | — |
| Completed | Nutritional Therapy for Diabetic Cardiomyopathy NCT01373814 | Washington University School of Medicine | — |